Structures by: Hemamalini M.
Total: 222
2-amino-5-chloropyridinium hydrogen glutarate
C5H6ClN2,C5H7O4
Acta Crystallographica Section E (2010) 66, 8 o2008-o2009
a=5.1970(14)Å b=14.509(4)Å c=15.970(5)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-4-methylpyridinium 3-carboxy-4-hydroxybenzenesulfonate monohydrate
C6H9N2,C7H5O6S,H2O
Acta Crystallographica Section E (2010) 66, 8 o2095-o2096
a=8.3280(9)Å b=24.122(3)Å c=7.9355(8)Å
α=90.00° β=112.800(3)° γ=90.00°
2-Amino-5-bromopyridine--4-hydroxybenzoic acid (1/1)
C5H5BrN2,C7H6O3
Acta Crystallographica Section E (2010) 66, 8 o1935-o1936
a=21.370(12)Å b=3.990(2)Å c=28.939(15)Å
α=90.00° β=90.00° γ=90.00°
2-amino-4-methylpyridinium salicylate
C6H9N2,C7H5O3
Acta Crystallographica Section E (2010) 66, 8 o2151-o2152
a=7.2417(2)Å b=12.5520(3)Å c=14.7699(3)Å
α=68.752(2)° β=82.038(2)° γ=88.824(2)°
Bis(2-amino-5-methylpyridinium) fumarate--fumaric acid (1/1)
C6H9N2,0.5(C4H4O42),0.5(C4H2O4)
Acta Crystallographica Section E (2010) 66, 8 o2093-o2094
a=4.0366(4)Å b=9.3145(10)Å c=14.0077(14)Å
α=94.030(3)° β=95.060(3)° γ=90.903(3)°
2-Amino-5-methylpyridinium 3-carboxy-4-hydroxybenzenesulfonate
C6H9N2,C7H5O6S
Acta Crystallographica Section E (2010) 66, 8 o2153-o2154
a=7.86350(10)Å b=10.88270(10)Å c=16.3907(2)Å
α=84.6120(10)° β=81.8020(10)° γ=86.2900(10)°
2-Amino-4-methylpyridinium hydrogen fumarate
C6H9N2,C4H3O4
Acta Crystallographica Section E (2010) 66, 8 o1962-o1963
a=5.0058(16)Å b=19.814(7)Å c=11.286(4)Å
α=90.00° β=108.332(13)° γ=90.00°
4-Aminopyridinium 4-carboxybutanoate
C5H7N2,C5H7O4
Acta Crystallographica Section E (2010) 66, 8 o2108
a=9.6159(2)Å b=10.3065(2)Å c=22.6801(5)Å
α=90.00° β=102.1430(10)° γ=90.00°
2-Amino-5-bromopyridinium 2-carboxybenzoate
C5H6BrN2,C8H5O4
Acta Crystallographica Section E (2010) 66, 9 o2269-o2270
a=9.0192(4)Å b=10.2689(5)Å c=14.4092(6)Å
α=82.269(2)° β=83.969(2)° γ=87.845(2)°
2-Cyanoquinolin-1-ium hydrogen sulfate
C10H7N2,HO4S
Acta Crystallographica Section E (2010) 66, 11 o2709
a=7.2154(3)Å b=8.2334(4)Å c=9.9985(4)Å
α=110.622(2)° β=90.982(3)° γ=110.791(2)°
2-Amino-5-methylpyridinium 1<i>H</i>-pyrazole-3,5-dicarboxylate trihydrate
2(C6H9N2),C5H2N2O4,3(H2O)
Acta Crystallographica Section E (2010) 66, 11 o2876-o2877
a=7.89850(10)Å b=9.21950(10)Å c=15.3922(2)Å
α=101.9420(10)° β=93.8830(10)° γ=104.6480(10)°
3,4-Diaminopyridinium 2-carboxy-4,6-dinitrophenolate
C5H8N3,C7H3N2O7
Acta Crystallographica Section E (2010) 66, 11 o2747
a=9.1187(4)Å b=11.3569(5)Å c=13.1343(6)Å
α=90.00° β=98.204(4)° γ=90.00°
2-Cyanoquinolin-1-ium nitrate
C10H7N2,NO3
Acta Crystallographica Section E (2010) 66, 11 o2726-o2727
a=3.69690(10)Å b=17.7031(3)Å c=14.6029(2)Å
α=90.00° β=95.8020(10)° γ=90.00°
5-[(<i>E</i>)-Benzylidene]-2-hydroxy-10-methyl-8-phenyl-3,10- diazahexacyclo[10.7.1.1^3,7^.0^2,11^.0^7,11^.0^16,20^]henicosa- 1(19),12(20),13,15,17-pentaen-6-one ethanol 0.25-solvate 0.6-hydrate
C33H28N2O2,0.25(C2H6O),0.6(H2O)
Acta Crystallographica Section E (2010) 66, 11 o2736-o2737
a=19.3839(3)Å b=19.3839(3)Å c=14.0757(2)Å
α=90.00° β=90.00° γ=90.00°
2-Amino-5-bromopyridinium 6-oxo-1,6-dihydropyridine-2-carboxylate monohydrate
C5H6BrN2,C6H4NO3,H2O
Acta Crystallographica Section E (2010) 66, 9 o2246-o2247
a=3.86160(10)Å b=15.8227(2)Å c=20.8961(3)Å
α=90.00° β=90.00° γ=90.00°
Tris(2-amino-5-chloropyridinium hydrogen phthalate) phthalic acid solvate
3(C5H6ClN2),3(C8H5O4),C8H6O4
Acta Crystallographica Section E (2010) 66, 10 o2535
a=9.8522(2)Å b=14.0242(2)Å c=17.4312(3)Å
α=68.9200(10)° β=87.5070(10)° γ=83.9060(10)°
8-Hydroxyquinolin-1-ium nitrate
C9H8NO,NO3
Acta Crystallographica Section E (2010) 66, 11 o2907-o2908
a=11.3186(2)Å b=6.75680(10)Å c=14.5006(2)Å
α=90.00° β=128.8820(10)° γ=90.00°
11-[(<i>E</i>)-4-Bromobenzylidene]-8-(4-bromophenyl)-14-hydroxy-3,13- diazaheptacyclo[13.7.1.1^9,13^.0^2,9^.0^2,14^.0^3,7^.0^19,23^]tetracosa- 1(22),15,17,19(23),20-pentaen-10-one
C35H28Br2N2O2
Acta Crystallographica Section E (2010) 66, 11 o2926-o2927
a=8.4833(10)Å b=11.8334(13)Å c=14.8942(17)Å
α=79.868(2)° β=80.705(2)° γ=77.359(2)°
Melaminium nitrate--melamine--water (1/1/1)
C3H7N6,NO3,C3H6N6,H2O
Acta Crystallographica Section E (2010) 66, 11 o3033-o3034
a=7.77590(10)Å b=9.00350(10)Å c=19.4573(3)Å
α=96.1820(10)° β=90.8540(10)° γ=99.8280(10)°
2-amino-5-methylpyridinium hydrogen phthalate
C6H9N2,C8H5O4
Acta Crystallographica Section E (2010) 66, 9 o2192-o2193
a=11.3853(2)Å b=8.8203(2)Å c=13.4617(3)Å
α=90.00° β=101.540(2)° γ=90.00°
Quinoline-2-carbonitrile--fumaric acid (1/0.5)
C10H6N2,0.5(C4H4O4)
Acta Crystallographica Section E (2010) 66, 9 o2357
a=3.72390(10)Å b=19.1958(3)Å c=13.6454(2)Å
α=90.00° β=93.8050(10)° γ=90.00°
4-({[4-Amino-5-(4-chloroanilinomethyl)-4<i>H</i>-1,2,4-triazol-3- yl]sulfanyl}acetyl)-3-(4-methoxyphenyl)-1,2,3-oxadiazol-3-ium-5-olate
C20H18ClN7O4S
Acta Crystallographica Section E (2010) 66, 12 o3178
a=20.109(3)Å b=5.8952(8)Å c=36.369(5)Å
α=90.00° β=96.076(3)° γ=90.00°
6-(4-Chlorophenyl)-2-isobutylimidazo[2,1-<i>b</i>][1,3,4]thiadiazole
C14H14ClN3S
Acta Crystallographica Section E (2011) 67, 1 o207
a=5.75520(10)Å b=26.4052(5)Å c=9.7662(2)Å
α=90.00° β=101.3880(10)° γ=90.00°
Ethyl 4-(1,3-dioxo-2,3-dihydro-1<i>H</i>-benzo[<i>de</i>]isoquinolin-2-yl)benzoate
C21H15NO4
Acta Crystallographica Section E (2011) 67, 1 o98-o99
a=5.2025(7)Å b=18.066(3)Å c=17.560(2)Å
α=90.00° β=98.365(2)° γ=90.00°
5-[(<i>E</i>)-(2-Hydroxybenzylidene)amino]-1<i>H</i>-1,3-benzimidazole- 2(3<i>H</i>)-thione
C14H11N3OS
Acta Crystallographica Section E (2011) 67, 1 o144-o145
a=8.2680(2)Å b=28.1043(6)Å c=10.5047(2)Å
α=90.00° β=92.2340(10)° γ=90.00°
4-Methoxyquinolinium-2-carboxylate dihydrate
C11H9NO3,2(H2O)
Acta Crystallographica Section E (2011) 67, 2 o435-o436
a=5.7674(11)Å b=21.196(4)Å c=10.0993(15)Å
α=90.00° β=115.978(8)° γ=90.00°
4-Hydroxy-3-[(4-hydroxy-6-methyl-2-oxo-3,6-dihydro-2<i>H</i>-pyran-3-yl)(3- thienyl)methyl]-6-methyl-3,6-dihydro-2<i>H</i>-pyran-2-one
C17H14O6S
Acta Crystallographica Section E (2011) 67, 2 o494-o495
a=30.6120(18)Å b=7.9982(5)Å c=25.6540(15)Å
α=90.00° β=90.00° γ=90.00°
1,3-bis(3-benzylimidazolium-1-ylmethyl)mesitylene dibromide
C31H34N42,2(Br)
Acta Crystallographica Section E (2011) 67, 3 o643
a=8.9851(2)Å b=12.8044(2)Å c=25.6419(5)Å
α=90.00° β=102.6110(10)° γ=90.00°
Bis(2,6-diaminopyridinium) bis(hydrogen oxalate) monohydrate
2(C5H8N3),2(C2HO4),H2O
Acta Crystallographica Section E (2011) 67, 3 o591-o592
a=8.16810(10)Å b=34.8396(4)Å c=7.20310(10)Å
α=90.00° β=114.5730(10)° γ=90.00°
2,4-Bis[(3-butylimidazol-3-ium-1-yl)methyl]-1,3,5-trimethylbenzene bis(hexafluorophosphate)
C25H38N42,2(F6P)
Acta Crystallographica Section E (2011) 67, 3 o562-o563
a=12.3851(2)Å b=19.6516(3)Å c=12.7586(2)Å
α=90.00° β=104.6980(10)° γ=90.00°
2,3-Dibromo-3-phenyl-1-(3-phenylsydnon-4-yl)propan-1-one
C17H12Br2N2O3
Acta Crystallographica Section E (2011) 67, 4 o814
a=11.9109(3)Å b=17.5018(3)Å c=8.5365(2)Å
α=90.00° β=94.9600(10)° γ=90.00°
2,3-Dibromo-3-(4-bromophenyl)-1-[3-(4-methoxyphenyl)sydnon-4-yl]propan-1-one
C18H13Br3N2O4
Acta Crystallographica Section E (2011) 67, 4 o951
a=7.80240(10)Å b=24.0261(3)Å c=10.82110(10)Å
α=90.00° β=108.8480(10)° γ=90.00°
7-Fluoro-4-oxochromene-3-carbaldehyde
C10H5FO3
Acta Crystallographica Section E (2011) 67, 4 o766
a=3.72940(10)Å b=6.2347(2)Å c=34.6518(11)Å
α=90.00° β=90.7400(10)° γ=90.00°
(<i>E</i>)-6-Bromo-3-{2-[2-(4-chlorobenzylidene)hydrazinyl]thiazol-5-yl}- 2<i>H</i>-chromen-2-one
C19H11BrClN3O2S
Acta Crystallographica Section E (2011) 67, 4 o1007-o1008
a=30.5837(7)Å b=13.6682(3)Å c=9.04540(10)Å
α=90.00° β=90.161(2)° γ=90.00°
(<i>E</i>)-6-Bromo-3-{2-[2-(2-chlorobenzylidene)hydrazinyl]thiazol-5-yl}- 2<i>H</i>-chromen-2-one dimethyl sulfoxide monosolvate
C19H11BrClN3O2S,C2H6OS
Acta Crystallographica Section E (2011) 67, 4 o1009-o1010
a=6.5806(4)Å b=15.7789(9)Å c=20.9378(13)Å
α=90.00° β=90.684(2)° γ=90.00°
4-[2-(2-Benzylidenehydrazinylidene)-3,6-dihydro-2<i>H</i>-1,3,4-thiadiazin- 5-yl]-3-(4-methoxyphenyl)sydnone
C19H16N6O3S
Acta Crystallographica Section E (2011) 67, 4 o902
a=14.9236(15)Å b=5.9331(7)Å c=21.425(2)Å
α=90.00° β=99.338(2)° γ=90.00°
1,1'-Bis(4-fluorophenyl)-3,3'-diisobutyl-4,4'-diphenoxy-1<i>H</i>,1'<i>H</i>-4,4'-bipyrazole-5,5'(4<i>H</i>,4'<i>H</i>)-dione
C38H36F2N4O4
Acta Crystallographica Section E (2011) 67, 5 o1036
a=11.3875(5)Å b=11.4582(5)Å c=13.4885(6)Å
α=90.00° β=109.7520(10)° γ=90.00°
4-(2-{2-[2-(2-Nitro-1<i>H</i>-imidazol-1-yl)ethoxy]ethoxy}ethoxy)benzaldehyde
C16H19N3O6
Acta Crystallographica Section E (2011) 67, 5 o1206
a=4.4403(3)Å b=11.4686(8)Å c=31.2763(19)Å
α=90.00° β=90.00° γ=90.00°
(3<i>E</i>,5<i>E</i>)-1-Acryloyl-3,5-bis(2-chlorobenzylidene)piperidin-4-one
C22H17Cl2NO2
Acta Crystallographica Section E (2011) 67, 5 o1228-o1229
a=9.1426(5)Å b=14.3459(8)Å c=16.6637(9)Å
α=108.3480(10)° β=102.6950(10)° γ=103.6490(10)°
(<i>E</i>)-3-(2-{2-[1-(3-Hydroxyphenyl)ethylidene]hydrazinyl}-1,3- thiazol-4-yl)-2<i>H</i>-chromen-2-one
C20H15N3O3S
Acta Crystallographica Section E (2011) 67, 5 o1072-o1073
a=9.15690(10)Å b=9.9070(2)Å c=18.7478(3)Å
α=90.00° β=92.0400(10)° γ=90.00°
2,3-diaminopyridinium hydrogen glutarate
C5H8N3,C5H7O4
Acta Crystallographica Section E (2011) 67, 11 o3123
a=7.70520(10)Å b=21.4626(4)Å c=7.84500(10)Å
α=90.00° β=119.4730(10)° γ=90.00°
1'-Methyl-4'-[4-(trifluoromethyl)phenyl]dispiro[indan-2,2'-pyrrolidine- 3',2''-indan]-1,3,1''-trione
C28H20F3NO3
Acta Crystallographica Section E (2011) 67, 11 o3125
a=7.8070(2)Å b=22.0878(5)Å c=13.1278(3)Å
α=90.00° β=101.420(2)° γ=90.00°
4'-(4-Bromophenyl)-1'-methyldispiro[indan-2,2'-pyrrolidine-3',2''-indan]- 1,3,1''-trione
C27H20BrNO3
Acta Crystallographica Section E (2011) 67, 11 o3124
a=7.83920(10)Å b=21.5849(5)Å c=12.7823(3)Å
α=90.00° β=98.4220(10)° γ=90.00°
<i>N</i>-Butyl-4,6-diphenylpyrimidin-2-amine
C20H21N3
Acta Crystallographica Section E (2011) 67, 11 o2956
a=8.15440(10)Å b=9.52840(10)Å c=11.3237(2)Å
α=77.0900(10)° β=74.1520(10)° γ=71.2880(10)°
Diisobutyl 4-(3-ethoxy-4-hydroxyphenyl)-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate
C25H35NO6
Acta Crystallographica Section E (2012) 68, 2 o287-o288
a=12.7346(2)Å b=13.1180(2)Å c=15.7404(2)Å
α=71.7660(10)° β=89.8130(10)° γ=76.1500(10)°
Ethyl 2-(4-bromophenyl)-1-[3-(1<i>H</i>-imidazol-1-yl)propyl]- 1<i>H</i>-benzimidazole-5-carboxylate monohydrate
C22H21BrN4O2,H2O
Acta Crystallographica Section E (2011) 67, 11 o3060
a=9.18540(10)Å b=16.7389(2)Å c=13.7379(2)Å
α=90.00° β=98.2830(10)° γ=90.00°
(<i>E</i>)-6-Bromo-3-{2-[2-(2-methoxybenzylidene)hydrazinyl]- 1,3-thiazol-4-yl}-2<i>H</i>-chromen-2-one
C20H14BrN3O3S
Acta Crystallographica Section E (2011) 67, 7 o1825
a=7.2802(12)Å b=19.551(3)Å c=14.0638(18)Å
α=90.00° β=113.352(7)° γ=90.00°
<i>N</i>,<i>N</i>'-[4,4'-Methylenebis(4,1-phenylene)]bis(2,6-difluorobenzamide)
C27H18F4N2O2
Acta Crystallographica Section E (2011) 67, 7 o1832
a=42.0478(10)Å b=5.29800(10)Å c=9.5643(2)Å
α=90.00° β=92.522(2)° γ=90.00°
Melitraceninium chloride
C21H26N,Cl
Acta Crystallographica Section E (2011) 67, 7 o1725
a=15.0129(18)Å b=8.8092(11)Å c=14.0135(17)Å
α=90.00° β=91.506(2)° γ=90.00°
2-[(<i>E</i>)-(2,4-Dichlorobenzylidene)amino]isoindoline-1,3-dione
C15H8Cl2N2O2
Acta Crystallographica Section E (2011) 67, 7 o1712
a=8.0387(8)Å b=7.6981(8)Å c=22.2686(19)Å
α=90.00° β=101.828(3)° γ=90.00°
(2<i>E</i>)-3-(1,3-Diphenyl-1<i>H</i>-pyrazol-4-yl)-1-phenylprop-2-en-1-one
C24H18N2O
Acta Crystallographica Section E (2011) 67, 7 o1745-o1746
a=8.1027(2)Å b=9.3157(2)Å c=12.9634(3)Å
α=73.6300(10)° β=74.7130(10)° γ=74.8200(10)°
4-{[(<i>E</i>)-(3-Phenyl-1<i>H</i>-pyrazol-4-yl)methylidene]amino}- 1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C12H10N6S
Acta Crystallographica Section E (2011) 67, 8 o1944
a=4.1180(4)Å b=17.9237(16)Å c=17.0787(15)Å
α=90.00° β=97.352(3)° γ=90.00°
Methyl pyrido[2,3-<i>b</i>]pyrazine-3-carboxylate
C9H7N3O2
Acta Crystallographica Section E (2011) 67, 11 o3120
a=9.51350(10)Å b=26.9042(3)Å c=6.78370(10)Å
α=90.00° β=107.6860(10)° γ=90.00°
6-Fluoro-2-(4-methoxyphenyl)imidazo[2,1-<i>b</i>][1,3]benzothiazole
C16H11FN2OS
Acta Crystallographica Section E (2011) 67, 12 o3265-o3266
a=7.6120(13)Å b=13.883(2)Å c=13.049(2)Å
α=90.00° β=105.117(3)° γ=90.00°
3-Benzyl-6-methyl-2-sulfanylidene-2,3-dihydroquinazolin-4(1<i>H</i>)-one
C16H14N2OS
Acta Crystallographica Section E (2012) 68, 3 o717-o718
a=24.2438(18)Å b=5.1618(5)Å c=24.4265(17)Å
α=90.00° β=111.532(6)° γ=90.00°
<i>N</i>-{2-[2,3-bis(methoxycarbonyl)guanido]-5-(phenylthio)phenyl}-\ 2-methoxyacetamide
C20H22N4O6S
Acta Crystallographica Section E (2012) 68, 3 o581-o582
a=10.6975(7)Å b=10.6921(7)Å c=18.3732(13)Å
α=90.00° β=91.0680(10)° γ=90.00°
4-Methyl-2-oxo-2<i>H</i>-chromen-7-yl 4-fluorobenzenesulfonate
C16H11FO5S
Acta Crystallographica Section E (2012) 68, 3 o641-o642
a=17.2983(4)Å b=5.33970(10)Å c=17.1669(4)Å
α=90.00° β=118.1950(10)° γ=90.00°
<i>N</i>'-(4-Fluorobenzylidene)-2-(4-fluorophenyl)acetohydrazide
C15H12F2N2O
Acta Crystallographica Section E (2011) 67, 11 o2835
a=13.8754(15)Å b=12.5349(13)Å c=7.7093(8)Å
α=90.00° β=93.566(2)° γ=90.00°
<i>N</i>'-(4-Chlorobenzylidene)-2-[4-(methylsulfanyl)phenyl]acetohydrazide
C16H15ClN2OS
Acta Crystallographica Section E (2011) 67, 11 o2847
a=17.0923(13)Å b=9.6719(7)Å c=9.5592(7)Å
α=90.00° β=92.3990(10)° γ=90.00°
(5<i>E</i>)-5-(2,4-Dichlorobenzylidene)-2-(piperidin-1-yl)- 1,3-thiazol-4(5<i>H</i>)-one
C15H14Cl2N2OS
Acta Crystallographica Section E (2011) 67, 11 o2884
a=28.5303(3)Å b=7.49150(10)Å c=15.4789(2)Å
α=90.00° β=116.4070(10)° γ=90.00°
<i>N</i>-Benzyl-4-methyl-6-phenylpyrimidin-2-amine
C18H17N3
Acta Crystallographica Section E (2011) 67, 11 o2932
a=8.29740(10)Å b=9.9316(2)Å c=10.7251(2)Å
α=115.7970(10)° β=93.0190(10)° γ=111.5650(10)°
2,3-diaminopyridinium salicylate
C5H8N3,C7H5O3
Acta Crystallographica Section E (2011) 67, 11 o3121
a=10.484(3)Å b=11.260(3)Å c=20.033(6)Å
α=90.00° β=90.00° γ=90.00°
2,3-Diaminopyridinium 3-carboxy-4-hydroxybenzenesulfonate monohydrate
C5H8N3,C7H5O6S,H2O
Acta Crystallographica Section E (2011) 67, 11 o3122
a=7.0407(7)Å b=15.5775(16)Å c=13.6244(12)Å
α=90.00° β=101.491(2)° γ=90.00°
5-[(<i>E</i>)-4-Fluorobenzylidene]-8-(4-fluorophenyl)-2-hydroxy-9- phenyl-3,10-diazahexacyclo[10.7.1.1^3,7^.0^2,11^.0^7,11^.0^16,20^]henicosa- 1(20),12,14,16,18-pentaen-6-one
C38H28F2N2O2
Acta Crystallographica Section E (2011) 67, 11 o2879-o2880
a=9.3269(3)Å b=11.8635(4)Å c=14.2095(4)Å
α=75.904(2)° β=74.726(2)° γ=77.627(2)°
14-Hydroxy-11-[(<i>E</i>)-4-methoxybenzylidene]-8-(4-methoxyphenyl)-5- thia-3,13- diazaheptacyclo[13.7.1.1^9,13^.0^2,9^.0^2,14^.0^3,7^.0^19,23^]tetracosa- 1(22),15(23),16,18,20-pentaen-10-one
C36H32N2O4S
Acta Crystallographica Section E (2011) 67, 11 o2881-o2882
a=10.62870(10)Å b=11.8672(2)Å c=12.6588(2)Å
α=84.4390(10)° β=75.1050(10)° γ=68.5530(10)°
Ethyl 1-[2-(morpholin-4-yl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1<i>H</i>- benzimidazole-5-carboxylate
C23H24F3N3O3
Acta Crystallographica Section E (2011) 67, 5 o1215
a=10.1463(2)Å b=10.5595(2)Å c=11.5775(2)Å
α=96.8680(10)° β=109.6380(10)° γ=110.8330(10)°
3β-acetoxyolean-11,12-aziridin-28,13-β-olide
C32H49NO4
Acta Crystallographica Section E (2011) 67, 5 o1220
a=13.0197(2)Å b=6.74600(10)Å c=32.0674(5)Å
α=90.00° β=100.6452(4)° γ=90.00°
6-Bromo-3-{2-[2-(diphenylmethylene)hydrazinyl]-1,3-thiazol-5-yl}- 2<i>H</i>-chromen-2-one chloroform monosolvate
C25H16BrN3O2S,CHCl3
Acta Crystallographica Section E (2011) 67, 5 o1079-o1080
a=8.0774(3)Å b=12.6782(5)Å c=14.4396(5)Å
α=114.157(2)° β=92.879(2)° γ=100.384(2)°
3,3'-[1,2-Phenylenebis(methylene)]bis(1-ethylbenzimidazolium) dibromide
C26H28N42,2(Br)
Acta Crystallographica Section E (2012) 68, 3 o573
a=9.7093(7)Å b=35.796(3)Å c=8.0340(6)Å
α=90.00° β=118.2300(10)° γ=90.00°
3-Acetyl-1-(3-methylphenyl)-5-phenyl-1<i>H</i>-pyrazole-4-carbonitrile
C19H15N3O
Acta Crystallographica Section E (2012) 68, 2 o485-o486
a=11.8544(8)Å b=7.6731(6)Å c=17.4048(15)Å
α=90.00° β=96.202(6)° γ=90.00°
Bis(2,3-Diaminopyridinium) phthalate dihydrate
2(C5H8N3),(C8H4O4),2(H2O)
Acta Crystallographica Section E (2012) 68, 2 o402
a=15.795(5)Å b=13.083(4)Å c=11.012(4)Å
α=90.00° β=115.194(5)° γ=90.00°
(<i>E</i>)-1-(1-Benzyl-5-methyl-1<i>H</i>-1,2,3-triazol-4-yl)-3-(4-fluorophenyl)prop-2-en-1-one
C19H16FN3O
Acta Crystallographica Section E (2011) 67, 10 o2776
a=12.4580(10)Å b=13.7528(11)Å c=19.3128(15)Å
α=90.00° β=100.183(2)° γ=90.00°
2-(5-Bromopyridin-3-yl)-5-[3-(4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine- 5-ylsulfonyl)thiophen-2-yl]-1,3,4-oxadiazole
C18H13BrN4O3S3
Acta Crystallographica Section E (2011) 67, 10 o2743-o2744
a=7.0327(14)Å b=7.6488(15)Å c=36.939(7)Å
α=90.00° β=91.315(5)° γ=90.00°
2-(Biphenyl-4-yl)-5-[3-(4,5,6,7-tetrahydrothieno[3,2-<i>c</i>]pyridine- 5-ylsulfonyl)thiophen-2-yl]-1,3,4-oxadiazole
C25H19N3O3S3
Acta Crystallographica Section E (2011) 67, 10 o2781-o2782
a=7.91080(10)Å b=12.09430(10)Å c=12.9498(2)Å
α=69.2530(10)° β=76.7940(10)° γ=77.4600(10)°
3-Benzyl-2-(furan-2-yl)-1,3-thiazolidin-4-one
C14H13NO2S
Acta Crystallographica Section E (2011) 67, 10 o2807-o2808
a=13.2901(2)Å b=9.63600(10)Å c=9.91520(10)Å
α=90.00° β=102.8550(10)° γ=90.00°
Diethyl 4-[2-(4-methoxyphenyl)-1<i>H</i>-pyrazol-3-yl]-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate
C23H27N3O5
Acta Crystallographica Section E (2011) 67, 6 o1417-o1418
a=8.58000(10)Å b=11.12860(10)Å c=11.49960(10)Å
α=94.4250(10)° β=99.1910(10)° γ=92.9920(10)°
Bis{2-[(<i>E</i>)-(4-fluorobenzyl)iminomethyl]-6-methoxyphenolato}palladium(II)
C30H26F2N2O4Pd
Acta Crystallographica Section E (2011) 67, 6 m759-m760
a=10.0025(4)Å b=11.0082(4)Å c=12.3152(4)Å
α=109.5500(10)° β=98.3680(10)° γ=90.0540(10)°
2-[(<i>E</i>)-(2,4-Dihydroxybenzylidene)azaniumyl]-3-phenylpropanoate
C16H15NO4
Acta Crystallographica Section E (2011) 67, 6 o1331-o1332
a=9.39430(10)Å b=6.89460(10)Å c=20.7251(3)Å
α=90.00° β=92.0650(10)° γ=90.00°
(3<i>E</i>,5<i>E</i>)-3,5-Dibenzylidene-1-[3-(piperidin-1- yl)propanoyl]piperidin-4-one
C27H30N2O2
Acta Crystallographica Section E (2011) 67, 6 o1299-o1300
a=9.7757(6)Å b=10.9562(6)Å c=20.9400(15)Å
α=93.0650(10)° β=96.5940(10)° γ=90.1150(10)°
Cholest-5-ene
C27H46
Acta Crystallographica Section E (2011) 67, 6 o1368
a=10.6938(2)Å b=19.4062(3)Å c=11.1763(2)Å
α=90.00° β=93.6630(10)° γ=90.00°
(3<i>E</i>,5<i>E</i>)-1-Acryloyl-3,5-bis(2,4-dichlorobenzylidene)piperidin-4-one hemihydrate
2(C22H15Cl4NO2),H2O
Acta Crystallographica Section E (2011) 67, 6 o1301-o1302
a=27.0296(12)Å b=11.3031(5)Å c=18.9580(14)Å
α=90.00° β=133.807(2)° γ=90.00°
Diethyl 4-[5-(biphenyl-4-yl)-1<i>H</i>-pyrazol-4-yl]-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate ethanol monosolvate
C28H29N3O4,C2H6O
Acta Crystallographica Section E (2011) 67, 7 o1768-o1769
a=34.884(2)Å b=10.2322(7)Å c=7.8449(6)Å
α=90.00° β=90.00° γ=90.00°
3,3'-[1,2-Phenylenebis(methylene)]bis(1-heptylbenzimidazolium) dibromide monohydrate
C36H48N42,2(Br),H2O
Acta Crystallographica Section E (2011) 67, 7 o1814-o1815
a=8.84940(10)Å b=14.7170(3)Å c=16.0838(2)Å
α=115.7050(10)° β=105.3800(10)° γ=91.9460(10)°
2-cyano-2-{2-[5,6-dimethyl-4-(thiophen-2-yl)-1<i>H</i>-pyrazolo[3,4- <i>b</i>]pyridin-3-yl]hydrazinylidene}acetate
C17H16N6O2S
Acta Crystallographica Section E (2011) 67, 8 o2145-o2146
a=8.0672(5)Å b=10.6460(7)Å c=20.5892(13)Å
α=90.00° β=90.3320(10)° γ=90.00°
2,4-Bis[(3-allylimidazolium-1-yl)methyl]mesitylene bis(hexafluoridophosphate)
C23H30N42,2(F6P)
Acta Crystallographica Section E (2011) 67, 8 o2068
a=11.9269(4)Å b=19.1480(6)Å c=12.4233(4)Å
α=90.00° β=103.4790(10)° γ=90.00°
Bis{2-[(<i>E</i>)-(4-fluorobenzyl)iminomethyl]-6-methoxyphenolato- κ^2^<i>N</i>,<i>O</i>^1^}nickel(II)
C30H26F2N2NiO4
Acta Crystallographica Section E (2011) 67, 8 m1010-m1011
a=5.0110(2)Å b=10.9309(4)Å c=12.2435(5)Å
α=109.631(2)° β=99.083(3)° γ=91.020(3)°
3,3'-Di-<i>n</i>-propyl-1,1'-[<i>p</i>-phenylenebis(methylene)]diimidazolium dibromide
C20H28N42,2(Br)
Acta Crystallographica Section E (2011) 67, 8 o1931
a=8.9420(2)Å b=11.2443(2)Å c=11.3536(2)Å
α=90.00° β=109.7160(10)° γ=90.00°
3,5-Diamino-4<i>H</i>-1,2,4-triazol-1-ium hydroxonium bis(pyridine-2,6-dicarboxylato)cobaltate(II) pyridine-2,6-dicarboxylic acid monohydrate
C2H6N5,H3O,C14H6CoN2O82,C7H5NO4,H2O
Acta Crystallographica Section E (2011) 67, 8 m1105-m1106
a=8.0209(2)Å b=9.2028(2)Å c=18.7004(4)Å
α=98.5360(10)° β=96.7210(10)° γ=100.5150(10)°
2-Amino-6-methylpyridinium 2-carboxybenzoate
C6H9N2,C8H5O4
Acta Crystallographica Section E (2011) 67, 9 o2402
a=7.473(2)Å b=8.386(3)Å c=11.818(4)Å
α=97.401(6)° β=102.940(7)° γ=109.616(6)°
<i>N</i>,<i>N</i>'-(Ethane-1,2-diyl)dibenzenesulfonamide
C14H16N2O4S2
Acta Crystallographica Section E (2011) 67, 9 o2214
a=5.2115(4)Å b=16.6905(13)Å c=17.8750(14)Å
α=90.00° β=93.187(2)° γ=90.00°
Naphthalen-1-aminium chloride
C10H10N,Cl
Acta Crystallographica Section E (2011) 67, 9 o2365
a=13.9691(11)Å b=5.2811(4)Å c=12.1640(10)Å
α=90.00° β=93.791(2)° γ=90.00°
3,3'-Diallyl-1,1'-[<i>o</i>-phenylenebis(methylene)]diimidazol-3-ium bis(hexafluorophosphate)
C20H24N42,2(F6P)
Acta Crystallographica Section E (2011) 67, 9 o2529-o2530
a=7.3151(3)Å b=12.4913(4)Å c=13.8569(5)Å
α=101.8100(10)° β=94.6030(10)° γ=91.4240(10)°
(2,6-Difluorophenyl)(4-methylpiperidin-1-yl)methanone
C13H15F2NO
Acta Crystallographica Section E (2011) 67, 9 o2409
a=9.1807(7)Å b=10.9910(8)Å c=13.2477(8)Å
α=90.00° β=115.582(4)° γ=90.00°
Bis(1-benzyl-3-methylimidazolium-κ<i>C</i>^2^)mercury(II) bis(hexafluoridophosphate)
C22H24F12HgN4P22,2(F6P)
Acta Crystallographica Section E (2011) 67, 9 m1242-m1243
a=15.1260(17)Å b=10.3044(11)Å c=26.398(3)Å
α=90.00° β=102.275(2)° γ=90.00°
<i>N</i>,<i>N</i>'-(Ethane-1,2-diyl)bis(4-chlorobenzenesulfonamide)
C14H14Cl2N2O4S2
Acta Crystallographica Section E (2011) 67, 9 o2241
a=13.2640(5)Å b=5.3390(2)Å c=13.1792(5)Å
α=90.00° β=110.2700(10)° γ=90.00°
Ethyl 4-(phenylsulfonyl)piperazine-1-carboxylate
C13H18N2O4S
Acta Crystallographica Section E (2011) 67, 9 o2401
a=6.1433(5)Å b=20.5966(17)Å c=12.5626(8)Å
α=90.00° β=114.026(3)° γ=90.00°
1,3-benzothiazole--oxalic acid (2/1)
2(C7H5NS),C2H2O4
Acta Crystallographica Section E (2011) 67, 9 o2342
a=4.0231(3)Å b=26.039(2)Å c=8.5605(6)Å
α=90.00° β=116.064(3)° γ=90.00°
2-(5,6-Dihydrobenzimidazo[1,2-<i>c</i>]quinazolin-6-yl)-5-methylphenol
C21H17N3O
Acta Crystallographica Section E (2011) 67, 9 o2373-o2374
a=15.1292(3)Å b=12.2648(2)Å c=17.1909(3)Å
α=90.00° β=96.2330(10)° γ=90.00°
2-Amino-4,6-dimethylpyridinium chloride dihydrate
C7H11N2,Cl,2(H2O)
Acta Crystallographica Section E (2011) 67, 10 o2572
a=7.5811(6)Å b=13.8149(11)Å c=10.6657(8)Å
α=90.00° β=109.261(2)° γ=90.00°
3-Benzyl-2-phenyl-1,3-thiazolidin-4-one
C16H15NOS
Acta Crystallographica Section E (2011) 67, 10 o2706
a=13.5734(15)Å b=10.1402(11)Å c=10.1496(11)Å
α=90.00° β=104.305(2)° γ=90.00°